Evaluation of prime/boost regimens using recombinant poxvirus/tyrosinase vaccines for the treatment of patients with metastatic melanoma.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Kimberly R LindseySuzanne L Topalian

Abstract

Two clinical trials were conducted to evaluate the clinical efficacy and immunologic impact of vaccination against the tyrosinase protein plus systemic interleukin 2 (IL-2) administration in patients with advanced metastatic melanoma. Full-length tyrosinase was employed as an immunogen to induce diverse immunologic responses against a commonly expressed melanoma antigen. Heterologous prime/boost vaccination with recombinant vaccinia and fowlpox vectors encoding tyrosinase was first explored in a randomized three-arm phase II trial, in which vaccines were administered alone or concurrently with low-dose or high-dose IL-2. In a subsequent single cohort phase II trial, all patients received the same vaccines and high-dose IL-2 sequentially rather than concurrently. Among a total of 64 patients treated on these trials, 8 objective partial responses (12.5%) were observed, all in patients receiving high-dose IL-2. Additional patients showed evidence of lesional regression (mixed tumor response) or overall regression that did not achieve partial response status (minor response). In vitro evidence of enhanced immunity against tyrosinase following protocol treatments was documented in 3 of 49 (6%) patients tested serologically, 3 of 23 ...Continue Reading

References

Mar 1, 1989·Controlled Clinical Trials·R Simon
Aug 29, 1995·Proceedings of the National Academy of Sciences of the United States of America·Y T ChenL J Old
Dec 5, 1995·Proceedings of the National Academy of Sciences of the United States of America·U SahinM Pfreundschuh
May 1, 1996·The Journal of Experimental Medicine·S L TopalianP F Robbins
Jul 3, 1996·International Journal of Cancer. Journal International Du Cancer·E JägerA Knuth
Oct 15, 1996·Proceedings of the National Academy of Sciences of the United States of America·B Moss
Oct 15, 1996·Proceedings of the National Academy of Sciences of the United States of America·E Paoletti
Oct 1, 1996·Current Opinion in Immunology·P F Robbins, Y Kawakami
Nov 15, 1997·Journal of the National Cancer Institute·K R IrvineN P Restifo
Dec 22, 1999·International Journal of Cancer. Journal International Du Cancer·S MorelG Degiovanni
Mar 17, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R M SimonJ A Berzofsky
Jun 18, 2002·Nature·Helen DaviesP Andrew Futreal
Mar 5, 2004·Cancer Research·Melinda S SharkeySuzanne L Topalian
Jun 1, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Howard L KaufmanLouis M Weiner
Sep 2, 2004·Nature Medicine·Steven A RosenbergNicholas P Restifo
Oct 2, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Udai S KammulaDaniel G Coit
Oct 16, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Paul B Chapman
Nov 16, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Craig L SlingluffPriscilla Merrill
Feb 19, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Christiane VoitUlrich Keilholz
Apr 1, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mark E DudleySteven A Rosenberg
Aug 10, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Peter AttiaSteven A Rosenberg
Feb 13, 2013·Clinical and Experimental Dermatology·G W M Millington

❮ Previous
Next ❯

Citations

Jul 16, 2009·Molecular Therapy : the Journal of the American Society of Gene Therapy·Byram W BridleYonghong Wan
Mar 22, 2007·Molecular Therapy : the Journal of the American Society of Gene Therapy·Barbara-ann GuinnAlbert B Deisseroth
Sep 29, 2011·The Cancer Journal·Cecilia Larocca, Jeffrey Schlom
Nov 12, 2010·Journal of Translational Medicine·Hideyuki NakashimaRaj K Puri
May 20, 2009·Future Oncology·Aaron S Mansfield, Svetomir N Markovic
Apr 20, 2012·Immunotherapy·Hideyuki NakashimaRaj K Puri
Jan 5, 2011·Clinical & Developmental Immunology·Georg EschenburgHolger N Lode
Apr 9, 2015·Viruses·Lucas Sánchez-SampedroMariano Esteban
Mar 12, 2010·Expert Review of Vaccines·Mudita PinchaRenata Stripecke
Sep 5, 2008·Expert Review of Vaccines·Lee B Riley, Sanjiv S Agarwala
Dec 20, 2008·Expert Review of Vaccines·Philippe Fournier, Volker Schirrmacher
Feb 21, 2007·Expert Opinion on Biological Therapy·Adam I RikerHung T Khong
Aug 30, 2008·Expert Opinion on Drug Delivery·Yin Hwa Lai, Chong Wang
May 19, 2012·Seminars in Oncology·Howard L Kaufman
May 1, 2009·Human Immunology·Marta E PolakIan A Cree
Nov 2, 2007·Vaccine·Neil L Berinstein
Jul 25, 2007·Vaccine·Alicia M TerandoDonald L Morton
Aug 19, 2007·Vaccine·Richard J Anderson, Joerg Schneider
Jul 25, 2007·Journal of Cellular Biochemistry·Lazar Vujanovic, Lisa H Butterfield
Jan 5, 2011·Immunological Reviews·Christopher A KlebanoffNicholas P Restifo
May 29, 2016·Pharmacology & Therapeutics·Angeliki Tiptiri-KourpetiKaterina Chlichlia
Jan 22, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Hansje-Eva TeulingsRosalie M Luiten
Feb 3, 2015·Current Protocols in Immunology·Zhiya YaNicholas P Restifo
May 22, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Tanja I NäslundPeter Liljeström
Nov 20, 2020·Molecular Therapy Oncolytics·Sandra S RingLukas Flatz

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.